
CRISPR Is Now Targeting Vitamin Deficiencies
CRISPR is like software programming for DNA, and U.K.-based researchers just demonstrated how to use it to stop tomatoes...
Editor, The Bleeding Edge, The Near Future Report, Exponential Tech Investor, Neural Net Profits, and Brownstone Unlimited
Jeff Brown is the founder and chief investment analyst for Brownstone Research. Before founding Brownstone Research, Jeff spent 25 years as a high-technology executive. He worked as an executive level for some of the best technology companies in the world, like Qualcomm, NXP Semiconductors, and Juniper Networks.
As an active and successful angel investor in early stage technology companies, he has access to information the public never sees. He is on the front line, in the field, seeing things months, if not years, before the mass market becomes aware.
Jeff has a wide range of technology industry experience. From semiconductors to mobility… to broadcasting and video technology… to technology infrastructure… to IT networking and security… to automotive and even consumer electronics… he’s done it all.
He has built organizations from the ground up and run divisions of companies generating hundreds of millions in revenue a year.
Though he was born, educated, and began his career in America, he spent two decades living and working in international markets, with much of that time spent in Tokyo, Japan. That gives him a unique global perspective on business, investing, and analysis.
Jeff earned his undergraduate degree in aeronautical and astronautical engineering from Purdue University. He also earned his master’s degree in management from the London Business School. Jeff is also an alumnus of Yale University’s School of Management.
In addition to formal degrees, Jeff has professional certificates from MIT, Stanford, UC Berkeley’s School of Law, and the National University of Singapore.
Jeff is an active board member and adviser to several companies and an active angel investor.
Today, Jeff uses his technology, business, finance, and investing expertise to help everyday investors discover companies on the verge of exponential growth.
CRISPR is like software programming for DNA, and U.K.-based researchers just demonstrated how to use it to stop tomatoes...
With the potential for more aggressive interest-rate hikes and rising inflation, it makes sense to approach this market with...
A recent Bleeding Edge topic, DeSoc, would provide a way to document and validate our key credentials. But our...
Volatility is scaring investors away from potentially groundbreaking investments, so where should we turn next? Jeff Brown has been...
With all of the fear in the market, Jeff has been keeping a close eye on indicators that allow...
While the stock market remains volatile, investors are on the hunt for any kind of “safe” investment they can...
With the focus on the Fed this week, Jeff takes a look at a policy tool we don’t usually...
The consumer price index (CPI) surprised the markets in the wrong way, with the worst inflation reading in four...
The crypto bank run sparked by Terra Luna's collapse has gotten lots of attention in the crypto world. It’s...